VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
-14.02%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$270M
AUM Growth
+$46.4M
Cap. Flow
+$80.5M
Cap. Flow %
29.85%
Top 10 Hldgs %
7.48%
Holding
501
New
128
Increased
202
Reduced
102
Closed
67

Top Buys

1
O icon
Realty Income
O
+$925K
2
LLY icon
Eli Lilly
LLY
+$843K
3
MRNA icon
Moderna
MRNA
+$824K
4
PFE icon
Pfizer
PFE
+$803K
5
MRK icon
Merck
MRK
+$796K

Top Sells

1
BPMP
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
+$1.76M
2
AEM icon
Agnico Eagle Mines
AEM
+$1.5M
3
MOS icon
The Mosaic Company
MOS
+$716K
4
STR
Sitio Royalties
STR
+$468K
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$424K

Sector Composition

1 Real Estate 18.55%
2 Healthcare 17.07%
3 Materials 11.98%
4 Financials 11.43%
5 Energy 8.64%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DNLI icon
326
Denali Therapeutics
DNLI
$2.27B
$142K 0.05%
4,839
+1,406
+41% +$41.3K
XNCR icon
327
Xencor
XNCR
$600M
$142K 0.05%
5,185
+593
+13% +$16.2K
KYMR icon
328
Kymera Therapeutics
KYMR
$3.09B
$141K 0.05%
7,171
+4,273
+147% +$84K
PHAT icon
329
Phathom Pharmaceuticals
PHAT
$882M
$141K 0.05%
16,726
+8,151
+95% +$68.7K
KURA icon
330
Kura Oncology
KURA
$707M
$139K 0.05%
7,592
-5,009
-40% -$91.7K
NTLA icon
331
Intellia Therapeutics
NTLA
$1.27B
$139K 0.05%
2,694
+1,341
+99% +$69.2K
EWTX icon
332
Edgewise Therapeutics
EWTX
$1.57B
$138K 0.05%
17,341
+9,212
+113% +$73.3K
FATE icon
333
Fate Therapeutics
FATE
$111M
$138K 0.05%
5,566
+2,475
+80% +$61.4K
NVAX icon
334
Novavax
NVAX
$1.26B
$138K 0.05%
2,679
+1,758
+191% +$90.6K
INBX
335
DELISTED
Inhibrx, Inc. Common Stock
INBX
$138K 0.05%
12,172
+8,204
+207% +$93K
NRIX icon
336
Nurix Therapeutics
NRIX
$742M
$136K 0.05%
10,735
+5,059
+89% +$64.1K
RXRX icon
337
Recursion Pharmaceuticals
RXRX
$2.02B
$136K 0.05%
16,726
+8,405
+101% +$68.3K
KRYS icon
338
Krystal Biotech
KRYS
$4.2B
$135K 0.05%
2,055
-144
-7% -$9.46K
RCKT icon
339
Rocket Pharmaceuticals
RCKT
$352M
$135K 0.05%
9,792
+3,000
+44% +$41.4K
ACET icon
340
Adicet Bio
ACET
$63.5M
$134K 0.05%
9,185
-1,678
-15% -$24.5K
ZNTL icon
341
Zentalis Pharmaceuticals
ZNTL
$118M
$134K 0.05%
4,786
+2,617
+121% +$73.3K
BCYC
342
Bicycle Therapeutics
BCYC
$496M
$133K 0.05%
7,946
+4,959
+166% +$83K
KRTX
343
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$133K 0.05%
1,048
-319
-23% -$40.5K
MRTX
344
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$133K 0.05%
1,975
+861
+77% +$58K
MCRB icon
345
Seres Therapeutics
MCRB
$200M
$132K 0.05%
1,920
+958
+100% +$65.9K
ALEC icon
346
Alector
ALEC
$279M
$131K 0.05%
12,898
+5,542
+75% +$56.3K
ARWR icon
347
Arrowhead Research
ARWR
$3.76B
$131K 0.05%
3,718
+1,460
+65% +$51.4K
IGMS
348
DELISTED
IGM Biosciences
IGMS
$131K 0.05%
7,267
+1,798
+33% +$32.4K
STOK icon
349
Stoke Therapeutics
STOK
$1.2B
$131K 0.05%
9,895
+1,336
+16% +$17.7K
ALLO icon
350
Allogene Therapeutics
ALLO
$253M
$130K 0.05%
11,383
+535
+5% +$6.11K
12 13
14
15 16